Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study
Clinical Chemistry · 2023
DOI: 10.1093/clinchem/hvad033 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Blanca Fabre-Estremera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, La Paz University Hospital, Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Troponin I, Myocardial Infarction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Our study addressed the diagnostic performance of the Atellica® IM High-Sensitivity Troponin I (hs-cTnI) assay for the rapid rule-out of myocardial infarction (MI) using a single hs-cTnI measurement at presentation in patients presenting to a US emergency department (ED).
Methods
This was a prospective, observational, cohort study of consecutive ED patients with suspected acute coronary syndrome, using 12-lead electrocardiogram and serial hs-cTnI measurements ordered on clinical indication (SAFETY, NCT04280926). ST-segment elevation MI patients were excluded. The optimal threshold required a sensitivity ≥99% and a negative predictive value (NPV) ≥99.5% for MI during index hospitalization as primary outcome. Type 1 MI (T1MI), myocardial injury, and 30-day adverse events were considered secondary outcomes. Event adjudications were established using the hs-cTnI assay used in clinical care.
Results
In 1171 patients, MI occurred in 97 patients (8.3%), 78.3% of which were type 2 MI. The optimal rule out hs-cTnI threshold was <10 ng/L, which identified 519 (44.3%) patients as low risk at presentation, with sensitivity of 99.0% (95% CI, 94.4–100) and NPV of 99.8% (95% CI, 98.9–100). For T1MI, sensitivity was 100% (95% CI, 83.9–100) and NPV 100% (95% CI, 99.3–100). Regarding myocardial injury, the sensitivity and NPV were 99.5% (95% CI, 97.9–100) and 99.8% (95% CI, 98.9–100), respectively. For 30-day adverse events, sensitivity was 96.8% (95% CI, 94.3–98.4) and NPV 97.9% (95% CI, 96.2–98.9).
Conclusions
A single hs-cTnI measurement strategy enabled the rapid identification of patients at low risk of MI and 30-day adverse events, allowing potential discharge early after ED presentation. Clinicaltrials.gov Registration number NCT04280926.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, La Paz University Hospital, Madrid, Madrid, Spain.
- Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Emergency Medicine at Hennepin Healthcare/Hennepin County Medical Center, University of Minnesota School of Medicine, Minneapolis, MN, United States.
- Minneapolis Heart Institute, Abbott Northwestern Hospital, and Minneapolis Heart Institute Foundation, Minneapolis, MN, United States.
- Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute, Minneapolis, MN, United States.
- Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Australia.
ORCID-Profile: Blanca Fabre-Estremera, Yader Sandoval, Louise Cullen
Zitieren
APA
Fabre-Estremera, B., Smith, S. W., Sandoval, Y., Schulz, K., Okeson, B., Cullen, L., & Apple, F. S. (2023). Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvad033
Vancouver
Fabre-Estremera B, Smith SW, Sandoval Y, Schulz K, Okeson B, Cullen L, et al. Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvad033
BibTeX
@article{FabreEstremera2023,
author = {Fabre-Estremera, Blanca and Smith, Stephen W and Sandoval, Yader and Schulz, Karen and Okeson, Brynn and Cullen, Louise and Apple, Fred S},
title = {Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study},
journal = {Clinical Chemistry},
year = {2023},
doi = {10.1093/clinchem/hvad033}
}
EUVIMED